Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer



      The purpose of this study was to evaluate the impact of cancer upon a patient's net worth and debt in the US.


      This longitudinal study used the Health and Retirement Study from 1998–2014. Persons ≥50 years with newly-diagnosed malignancies were included, excluding minor skin cancers. Multivariable generalized linear models assessed changes in net worth and debt (consumer, mortgage, home equity) at 2 and 4 years after diagnosis (year+2, year+4), controlling for demographic and clinically-related variables, cancer-specific attributes, economic factors, and mortality. A 2-year period before cancer diagnosis served as a historical control.


      Across 9.5 million estimated new diagnoses of cancer from 2000–2012, individuals averaged 68.6±9.4 years with slight majorities being married (54.7%), not retired (51.1%), and Medicare beneficiaries (56.6%). At year+2, 42.4% depleted their entire life's assets, with higher adjusted odds associated with worsening cancer, requirement of continued treatment, demographic and socioeconomic factors (ie, female, Medicaid, uninsured, retired, increasing age, income, and household size), and clinical characteristics (ie, current smoker, worse self-reported health, hypertension, diabetes, lung disease) (P<.05); average losses were $92,098. At year+4, financial insolvency extended to 38.2%, with several consistent socioeconomic, cancer-related, and clinical characteristics remaining significant predictors of complete asset depletion.


      This nationally-representative investigation of an initially-estimated 9.5 million newly-diagnosed persons with cancer who were ≥50 years of age found a substantial proportion incurring financial toxicity. As large financial burdens have been found to adversely affect access to care and outcomes among cancer patients, the active development of approaches to mitigate these effects among already vulnerable groups remains of key importance.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Cancer Society
        Cancer F acts & F igures .
        American Cancer Society, Atlanta, GA2018: 2018
        • Amir Z
        • Wilson K
        • Hennings J
        • et al.
        The meaning of cancer: Implications for family finances and consequent impact on lifestyle, activities, roles and relationships.
        Psychooncology. 2012; 21: 1167-1174
        • American Cancer Society
        Cancer F acts & F igures 2008 S pecial S ection: Insurance and C ost- R elated B arriers to C ancer C are .
        American Cancer Society, Atlanta, GA2008
        • Howard DH
        • Molinari NA
        • Thorpe KE
        National estimates of medical costs incurred by nonelderly cancer patients.
        Cancer. 2004; 100: 883-891
        • de Boer AGEM
        • Taskila, T
        • Ojajarvi A
        • et al.
        Cancer survivors and unemployment: a meta-analysis and meta-regression.
        JAMA. 2009; 301: 753-762
        • Arozullah AM
        • Calhoun EA
        • Wolf M
        • et al.
        The financial burden of cancer: estimates from a study of insured women with breast cancer.
        J Support Oncol. 2004; 2: 271-278
        • Zafar SY
        • Abernathy AP
        Financial toxicity, Part I: a new name for a growing problem.
        Oncology. 2013; 27: 80-81
        • Carrera PM
        • Kantarjian HM
        • Blinder VS
        The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment.
        Ca Cancer J Clin. 2018; 68: 153-165
        • Schnipper LE
        • Davidson NE
        • Wollins DS
        • et al.
        Updating the American Society of Clinical Oncology value framework: revisions and reflections in response to comments received.
        J Clin Oncol. 2016; 34: 2925-2934
        • St. Clair P
        • Blake D
        • Bugliari D
        • et al.
        RAND HRS D ata D ocumentation (Version K). Santa Monica, CA.
        RAND Center for the Study of Aging. 2011;
        • Heeringa S
        • Connor J
        Technical D escription of the H ealth and R etirement S tudy S urvey S ample Designs (No. 1). Ann Arbor.
        MI: University of Michigan Survey Research Center. 1995;
        • US Bureau of Labor Statistics, Consumer Price Index, 2017
        (Available at:) (Accessed May 5])
        • Andersen RM
        Revisiting the behavioral model and access to medical care: Does it matter?.
        J Health Soc Behav. 1995; 36: 1-C
        • Kaplan, ER Pamuk, JW Lynch, GA
        • et al.
        Inequality in income and mortality in the United States: analysis of mortality and potential pathways.
        Brit Med J. 1996; 312: 999-1003
        • Modigliani F
        The life cycle hypothesis of saving, the demand for wealth and the supply of capital.
        Soc Res. 1966; 33: 160-217
        • Skrepnek GH
        • Olvey EL
        • Sahai A
        Econometric approaches in evaluating costs and outcomes within pharmacoeconomic analyses.
        Pharm Policy Law. 2012; 14: 105-122
        • Himmelstein D
        • Thorne D
        • Warren E
        • et al.
        Medical bankruptcy in the United States, 2007: Results of a national study.
        Am J Med. 2009; 122: 741-746
        • Ramsey S
        • Blough D
        • Kirchhoff A
        • et al.
        Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.
        Health Aff. 2013; 6: 1143-1152
        • Brown ML
        • Riley GF
        • Schussler N
        • et al.
        Estimating health care costs related to cancer treatment from SEER-Medicare data.
        Med Care. 2002; 40: 104-117
        • Riley GF
        • Potosky AL
        • Lubitz JD
        • et al.
        Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
        Med Care. 1995; 33: 828-841
        • Yabroff KR
        • Lamont EB
        • Mariotto A
        • et al.
        Cost of care for elderly cancer patients in the United States.
        J Ntl Cancer Inst. 2008; 100: 630-641
        • Yabroff KR
        • Warren JL
        • Banthin J
        • et al.
        Comparison of approaches for estimating prevalence costs of care for cancer patients: What is the impact of data source?.
        Med Care. 2009; 47: s64-69
        • Murphy CC
        • Fullington HM
        • Alvarez CA
        • et al.
        Polypharmacy and patterns of prescription medication use among cancer survivors.
        Cancer. 2018; : 1-8
        • Yabroff KR
        • Lund J
        • Kepka D
        • et al.
        Economic burden of cancer in the United States: estimates, projections, and future research.
        Cancer Epidemiol Biomarkers Prev. 2011; 20: 2006-2014
        • Dean LT
        • Schmitz KH
        • Frick KD
        • et al.
        Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors.
        J Cancer Surviv. 2018; 12: 306-315
        • American Cancer Society
        The Cancer Atlas .
        American Cancer Society, 2017 (Available at:) (Accessed June 14)
        • Tang DH
        • Alberts DS
        • Nevins R
        • Sullivan S
        • Skrepnek GH
        Health care expenditures, hospitalizations, and productivity associated with cancer in US employer settings.
        J Occup Environ Med. 2012; 54: 1453-1460
        • Dusetzina SB
        • Winn AN
        • Abel GA
        • et al.
        Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.
        J Clin Oncol. 2014; 32: 306-311
        • Hershman DL
        • Kushi LH
        • Shao T
        • et al.
        Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
        J Clin Oncol. 2010; 28: 4120-4128
        • Kelley RK
        • Venook AP
        Nonadherence to imatinib during an economic downturn.
        N Engl J Med. 2010; 363: 596-598
        • Sedjo RL
        • Devine S
        Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.
        Breast Cancer Res Treat. 2011; 125: 191-200
        • Institute of Medicine
        Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis .
        National Academies Press, Washington, DC2013
        • Weaver KE
        • Rowland JH
        • Bellizzi KM
        • et al.
        Forgoing medical care because of cost: Assessing disparities in healthcare access among cancer survivors living in the United States.
        Cancer. 2010; 116: 3493-3504
        • Kaiser Family Foundation
        National survey of households affected by cancer .
        Kaiser Family Foundation, Washington, DC2006
        • Guy GP
        • Ekwueme DU
        • Yabroff KR
        • et al.
        Economic burden of cancer survivorship among adults in the United States.
        J Clin Oncol. 2013; 31: 3749-3757
        • Ramsey SD
        • Bansal A
        • Fedorenko CR
        • et al.
        Financial insolvency as a risk factor for early mortality among patients with cancer.
        J Clin Oncol. 2016; 34: 980-986
        • Pool LR
        • Burgard SA
        • Needham BL
        • et al.
        Association of negative wealth shock with all-cause mortality in middle-aged and older adults in the United States.
        JAMA. 2018; 319: 1341-1350
        • Moffitt RA
        The Great Recession and the social safety net.
        Ann Am Acad Pol Soc Sci. 2013; 650: 143-166
        • Raucher E
        • Elliot W
        Wealth as security: growth curve analyses of household income and net worth during a recession.
        J Fam Econ Issues. 2016; 37: 29-41
        • Liao M
        Changes in E conomic W ell- B eing of the E lderly. New York, NY: City University of New York (CUNY).
        Academic Works. 2015;
        • Brown S
        • Taylor K
        Household debt and financial assets: Evidence from Germany, Great Britain, and the USA.
        J R Stat Soc Ser A Stat Soc. 2008; 171: 615-643
        • Whitney RL
        • Bell J
        • Reed S
        • et al.
        Work and financial disparities among adult cancer survivors in the United States.
        J Clin Oncol. 2014; 32: 31s
        • Narang AK
        • Nicholas LH
        Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer.
        JAMA Oncol. 2017; 3: 757-765
        • DH Taylor Jr
        • Danis M
        • Zafar SY
        • et al.
        There is a mismatch between the Medicare benefit package and the preferences of patients with cancer and their caregivers.
        J Clin Oncol. 2014; 32: 3163-3168
        • Moy B
        • Abernethy AP
        • Peppercorn JM
        Core elements of the Patient Protection and Affordable Care Act and their relevance to the delivery of high-quality cancer care.
        Am Soc Clin Oncol Educ Book. 2012; : e4-e8
        • Institute of Medicine and National Research Council
        From Cancer Patient to Cancer Survivor: Lost in Transition .
        The National Academies Press, Washington, DC2005
        • National Comprehensive Cancer Network
        Distress management. Clinical practice guidelines.
        J Natl Compr Canc Netw. 2003; 1: 344
        • Xiang X
        • Larrison CR
        • Tabb KM
        Trends in health care utilization among adults with serious psychological distress: 2003-2014.
        Psychiatr Serv. 2016; 67: 743-748
        • Xiang X
        • An R
        • Gehlert S
        Trends in antidepressant use among US cancer survivors, 1999-2012.
        Psychiatr Serv. 2015; 66: 564